SBS-IF Hub
Initiated, funded and developed by Takeda
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.
Watch and catch-up! Informative videos, previous webinars and meeting recordings, initiated and funded by Takeda
The use of Revestive▼(teduglutide) will be discussed in recordings.
START WITH ONE - Glasgow SBS-IF Service and Adult Patient Selection, Initiation and Experience - Chaptered Video (11mins)
Watch Here
START WITH ONE - Paediatric Patient Selection & Initiation - Chaptered Video (16mins)
Watch Here
IF Illuminate Adult Patient Multidisciplinary Team (MDT) Case Study Overview - (16 mins)
Watch Here
Prof. Francisca Joly - Therapeutic Management of Patients with SBS-IF (3 mins)
Watch Here
Prof. Francisca Joly - Patient Suitability for Treatment (3 mins)
Watch Here
Prof. Francisca Joly - Real-World Experience, Efficacy and Safety Profile in Treatment (5 mins)
Watch Here
BAPEN 2024 Satellite Symposium Recording
Watch Here
IF Illuminate Paediatric Patient Multidisciplinary Team (MDT) Case Study Overview - (20 mins)
Watch Here
Register for an account to attend online events, catch up with on-demand webinars, and access exclusive promotional content on Takeda Products